BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 16416686)

  • 41. Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria.
    Vutuc C; Haidinger G; Waldhoer T; Ahmad F; Breitenecker G
    Wien Klin Wochenschr; 1999 May; 111(9):354-9. PubMed ID: 10407996
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cervical cancer screening programme in Primorsko-Goranska County, Croatia--the results of the pilot study.
    Vrdoljak-Mozetic D; Ostojić DV; Stemberger-Papić S; Janković S; Glibotić-Kresina H; Brncić-Fischer A; Benić-Salamon K
    Coll Antropol; 2010 Mar; 34(1):225-32. PubMed ID: 20437641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An evaluation of cervical cancer in women age sixty and over.
    Fox KV; Shah CA; Swisher EM; Garcia RL; Mandel LS; Gray HJ; Swensen RE; Goff BA
    Gynecol Oncol; 2008 Apr; 109(1):53-8. PubMed ID: 18255127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sentinel Pap smears in 261 invasive cervical cancer patients in Italy.
    Igidbashian S; Maggioni A; Casadio C; Boveri S; Cristoforoni P; Sideri M
    Vaccine; 2009 May; 27 Suppl 1():A34-8. PubMed ID: 19480959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CAPRELA (Cancer Prevention for Latinas): findings of a pilot study in Winston-Salem, Forsyth County.
    Koval AE; Riganti AA; Foley KL
    N C Med J; 2006; 67(1):9-15. PubMed ID: 16550986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pap screening in a U.S. health plan.
    Insinga RP; Glass AG; Rush BB
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):355-60. PubMed ID: 15006908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening for cervical cancer: will women accept less?
    Sirovich BE; Woloshin S; Schwartz LM
    Am J Med; 2005 Feb; 118(2):151-8. PubMed ID: 15694900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The cervical smear pattern in patients with chronic pelvic inflammatory disease.
    Abdul MA; Shittu SO; Randawa JA; Shehu MS
    Niger J Clin Pract; 2009 Sep; 12(3):289-93. PubMed ID: 19803028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pap smear screening in family physicians' offices in a rural area with a high cervical cancer rate.
    Oleszkowicz KL; Kresch GM; Painter JT
    Fam Med; 1994; 26(10):648-50. PubMed ID: 7859958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
    Cibas ES; Hong X; Crum CP; Feldman S
    Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Are analyses of cytological cervix smears from young women more harmful than beneficial?].
    Skjeldestad FE; Hagen B; Hagmar B; Iversen OE; Juvkam KH; Steen R; Thoresen S; Hareide B
    Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1782-5. PubMed ID: 17599128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Papanicolaou smear as a sentinel screening test for health screening in women.
    Hueston WJ; Stiles MA
    Arch Intern Med; 1994 Jul; 154(13):1473-7. PubMed ID: 8018002
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
    Martin-Hirsch P; Rash B; Martin A; Standaert B
    BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
    Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
    Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
    Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
    Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
    Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cervical screening in elderly women in Singapore.
    Ho T; Yoong T
    Singapore Med J; 1996 Feb; 37(1):61-5. PubMed ID: 8783916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The burden of prevention: downstream consequences of Pap smear testing in the elderly.
    Sirovich BE; Gottlieb DJ; Fisher ES
    J Med Screen; 2003; 10(4):189-95. PubMed ID: 14738656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The relationship of Papanicolaou testing and contacts with the medical care system to stage at diagnosis of cervical cancer.
    Norman SA; Talbott EO; Kuller LH; Stolley PD; Dunn MS; Baffone K; Klionsky B; Weinberg GB
    Arch Intern Med; 1991 Jan; 151(1):58-64. PubMed ID: 1985610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of Pap smear screening results between Akha hill tribe and urban women in Chiang Rai province, Thailand.
    Kritpetcharat O; Wutichouy W; Sirijaichingkul S; Kritpetcharat P
    Asian Pac J Cancer Prev; 2012; 13(11):5501-4. PubMed ID: 23317207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.